amifostine anhydrous and Chronic Kidney Failure studies

amifostine anhydrous and Chronic Kidney Failure

Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.

Research Excerpts

Excerpt	Relevance	Reference
" Chronic administration of WR-2721 (20 mg = 0."	1.27	Protection from progressive renal failure and hyperparathyroid bone remodeling by WR-2721. ( Bonjour, JP; Caverzasio, J; Charhon, S; Hirschel-Scholz, S; Paunier, L; Rizzoli, R, 1988)

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (66.67)	18.7374
1990's	1 (33.33)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Timeframe

Studies, this research(%)

All Research%

pre-1990

2 (66.67)

18.7374

1990's

1 (33.33)

18.2507

2000's

0 (0.00)

29.6817

2010's

0 (0.00)

24.3611

2020's

0 (0.00)

2.80

Authors

Authors	Studies
Treskes, M	1
van der Vijgh, WJ	1
Hirschel-Scholz, S	1
Charhon, S	1
Rizzoli, R	1
Caverzasio, J	1
Paunier, L	1
Bonjour, JP	1
Zingraff, J	1
Bourdeau, A	1
Clair, F	1
Kindermans, C	1
Buisson, C	1
Manganella, G	1
Sachs, C	1
Drüeke, T	1

Studies

Treskes, M

van der Vijgh, WJ

Hirschel-Scholz, S

Charhon, S

Rizzoli, R

Caverzasio, J

Paunier, L

Bonjour, JP

Zingraff, J

Bourdeau, A

Clair, F

Kindermans, C

Buisson, C

Manganella, G

Sachs, C

Drüeke, T

Reviews

1 review available for amifostine anhydrous and Chronic Kidney Failure

Article	Year
WR2721 as a modulator of cisplatin- and carboplatin-induced side effects in comparison with other chemoprotective agents: a molecular approach. Cancer chemotherapy and pharmacology, 1993, Volume: 33, Issue:2 Topics: Amifostine; Animals; Bone Marrow Diseases; Carboplatin; Cisplatin; Ear Diseases; Gastrointestinal Di	1993

Article

Year

WR2721 as a modulator of cisplatin- and carboplatin-induced side effects in comparison with other chemoprotective agents: a molecular approach.

Cancer chemotherapy and pharmacology, 1993, Volume: 33, Issue:2

Topics: Amifostine; Animals; Bone Marrow Diseases; Carboplatin; Cisplatin; Ear Diseases; Gastrointestinal Di

1993

Other Studies

2 other studies available for amifostine anhydrous and Chronic Kidney Failure

Article	Year
Protection from progressive renal failure and hyperparathyroid bone remodeling by WR-2721. Kidney international, 1988, Volume: 33, Issue:5 Topics: Amifostine; Animals; Bone Resorption; Calcium; Hyperparathyroidism, Secondary; Kidney Failure, Chron	1988
Hypocalcaemic effect of WR-2721, S-2 (3-aminopropylamino) ethyl-phosphorothioic acid in an anuric haemodialysis patient. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1987, Volume: 2, Issue:1 Topics: Amifostine; Female; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Kidney Failure, Chronic;	1987

Article

Year

Protection from progressive renal failure and hyperparathyroid bone remodeling by WR-2721.

Kidney international, 1988, Volume: 33, Issue:5

Topics: Amifostine; Animals; Bone Resorption; Calcium; Hyperparathyroidism, Secondary; Kidney Failure, Chron

1988

Hypocalcaemic effect of WR-2721, S-2 (3-aminopropylamino) ethyl-phosphorothioic acid in an anuric haemodialysis patient.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1987, Volume: 2, Issue:1

Topics: Amifostine; Female; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Kidney Failure, Chronic;

1987